Global Gaucher’s Disease Market Size, Growth, Analysis, Trends, and Opportunities-2018
Summary: A new market study, titled “EPIOMIC EPIDEMIOLOGY SERIES: GAUCHER’S DISEASE FORECAST IN 30 MAJOR MARKETS 2018–2028”, has been featured on WiseGuyReports. Report Description: The Epidemiology Series Forecast Report on Gaucher’s Disease in 30 Major Markets Gaucher’s Disease (GD) is caused by an inherited, autosomal recessive mutation in the GBA gene. This gene is responsible for providing the instructions for the production of the enzyme glucocerebrosidase. Without this enzyme, glucocerebroside and other similar substances can accumulate in macrophages and monocytes (white blood cells) and are deposited in various organs, including the spleen, liver, kidneys and lungs. This build-up can reach toxic levels which results in organ and tissue damage. This report provides the current prevalent population for GD across 30 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Belgium, Norway, Sweden, Finland, Denmark, Austria, Greece, Romania, Slove...